American cutaneous leishmaniasis. Inefficacy of metronidazole in treatment.
D000293:Adolescent; D000328:Adult; D000606:Amino Sugars / Q000627:therapeutic use; D000965:Antimony / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D004341:Drug Evaluation; D005500:Follow-Up Studies; D005942:Gluconates / Q000627:therapeutic use; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007891:Leishmania / Q000187:drug effects; D007897:Leishmaniasis, Mucocutaneous / Q000188:drug therapy*; D007962:Leukocytes / Q000187:drug effects; D008795:Metronidazole / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D008875:Middle Aged; D013012:Sorbitol / Q000627:therapeutic use; D013997:Time Factors
D000606:Amino Sugars; D000981:Antiprotozoal Agents; D005942:Gluconates; D008795:Metronidazole; D013012:Sorbitol; D000965:Antimony